Full year 2023 revenue, net loss and adjusted EBITDAA of $609.5 million, $(32.2) million and $73.0 million, respectively
Revenue, net loss and adjusted EBITDA of...
Represents 8th Consecutive Year of 20% or More Constant Currency Revenue Growth
ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader...
NEW YORK–(BUSINESS WIRE)–Ziff Davis, Inc. (NASDAQ: ZD) (“Ziff Davis” or “the Company”) today reported unaudited financial results for the fourth quarter and year ended...
POTOMAC, Md.–(BUSINESS WIRE)–#AD–IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the third fiscal quarter of 2024...